Similar articles

• Long term effects of thrombolytic therapy in acute myocardial infarction.

  Shah LS. Shah LS. J Assoc Physicians India. 1994 Jan;42(1):9-11. J Assoc Physicians India. 1994. PMID: 7836276 No abstract available.
• Thrombolytic agents in clinical medicine.

  Verstraete M. Verstraete M. Adv Intern Med. 1988;33:119-41. Adv Intern Med. 1988. PMID: 3125722 Review. No abstract available.
• Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.

  Sabatine MS, Morrow DA, Giugliano RP, Murphy SA, Demopoulos LA, DiBattiste PM, Weintraub WS, McCabe CH, Antman EM, Cannon CP, Braunwald E. Sabatine MS, et al. Circulation. 2004 Feb 24;109(7):874-80. doi: 10.1161/01.CIR.0000112604.74713.35. Epub 2004 Feb 2. Circulation. 2004. PMID: 14757697
• Thrombolytic therapy for unstable angina.

  Borzak S, Verter J, Bajwa HS, Lesch M. Borzak S, et al. Clin Cardiol. 1993 Sep;16(9):637-42. doi: 10.1002/clc.4960160903. Clin Cardiol. 1993. PMID: 8242907 Review.
• [Acute coronary syndromes with ST-segment elevation: fibrinolytic therapy].

  Cuccia C. Cuccia C. Ital Heart J. 2003 Dec;4 Suppl 8:9S-15S. Ital Heart J. 2003. PMID: 15005523 Review. Italian. No abstract available.